IFN-γ-regulated Toxoplasma gondii distribution and load in the murine eye

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 10, 2003, Pages 4375-4381

  Norose, Kazumi ^a   Mun, Hye Seong ^a   Aosai, Fumie ^a   Chen, Mei ^a   Piao, Lian Xun ^a   Kobayashi, Masashi ^a   Iwakura, Yoichiro ^b   Yano, Akihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; IMMUNE DEFICIENCY; MOUSE; MOUSE STRAIN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA CAPILLARY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIGENS, PROTOZOAN; BRAIN; DISEASE MODELS, ANIMAL; EYE; FLUORESCEIN ANGIOGRAPHY; HEAT-SHOCK PROTEINS; HSP30 HEAT-SHOCK PROTEINS; IMMUNOCOMPROMISED HOST; INTERFERON TYPE II; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTOZOAN PROTEINS; RETINAL VASCULITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

EID: 0141430085     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0156     Document Type: Article

References (49)

1. Gagliuso DJ, Teich SA, Friedman AH, Orellana J. Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc. 1990;88:63-86; discussion 86-88.
2. Nicholson DH, Wolchok EB. Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy. Arch Ophthalmol. 1976;94:248-254.
3. Singer MA, Hagler WS, Grossniklaus HE. Toxoplasma gondii retinochoroiditis after liver transplantation. Retina. 1993;13:40-45.
4. Israelski DM, Remington JS. Toxoplasmosis in the non-AIDS immunocompromised host. Curr Clin Top Infect Dis. 1993;13:322-356.
5. McMenamin PG, Dutton GN, Hay J, Cameron S. The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part I: the localization and morphology of Toxoplasma cysts in the retina. Exp Eye Res. 1986;43:529-543.
6. Davidson MG, Lappin MR, English RV, Tompkins MB. A feline model of ocular toxoplasmosis. Invest Ophthalmol Vis Sci. 1993;34:3653-3660.
7. Gormley PD, Pavesio CE, Luthert P, Lightman S. Retinochoroiditis is induced by oral administration of Toxoplasma gondii cysts in the hamster model. Exp Eye Res. 1999;68:657-661.
8. Hu MS, Schwartzman JD, Yeaman GR, et al. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infect Immun. 1999;67:928-935.
9. Pavesio CEN, Chiappino ML, Gormley P, Setzer PY, Nichols BA. Acquired retinochoroiditis in hamsters inoculated with ME 49 strain Toxoplasma. Invest Ophthalmol Vis Sci. 1995;36:2166-2175.
10. Shen DF, Matteson DM, Tuaillon N, Suedekum BK, Buggage RR, Chan CC. Involvement of apoptosis and interferon-γ in murine toxoplasmosis. Invest Ophthalmol Vis Sci. 2001;42:2031-2036.
11. Gazzinelli RT, Brézin A, Li Q, Nussenblatt RB, Chan CC. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ. Exp Parasitol. 1994;78:217-229.
12. Suzuki Y, Conley FK, Remington JS. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J Immunol. 1989;143:2045-2050.
13. Scharton-Kersten TM, Wynn TA, Denkers EY, et al. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol. 1996;157:4045-4054.
14. Kobayashi M, Aosai F, Hata H, et al. Toxoplasma gondii: difference of invasion into tissue of digestive organs between susceptible and resistant strain and influence of IFN-γ in mice inoculated with the cysts perorally. J Parasitol. 1999;85:973-975.
15. Norose K, Mun H-S, Aosai F, et al. Organ infectivity of Toxoplasma gondii in interferon-γ knockout mice. J Parasitol. 2001;87:447-452.
16. Murray HW, Hillman JK, Rubin BY, et al. Patients at risk for AIDS-related opportunistic infections: clinical manifestations and impaired gamma interferon production. N Engl J Med. 1985;313:1504-1510.
17. Burg JL, Perelman D, Kasper LH, Ware PL, Boothroyd JC. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol. 1988;141:3584-3591.
18. Luo W, Seki T, Yamashita K, Aosai F, Ueda M, Yano A. Quantitative detection of Toxoplasma gondii by competitive polymerase chain reaction of the surface specific antigen gene-1. Jpn J Parasitol. 1995;44:183-190.
19. Bohne W, Gross U, Ferguson DJP, Heesemann J. Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol. 1995;16:1221-1230.
20. Williams DM, Grumet FC, Remington JS. Genetic control of murine resistance to Toxoplasma gondii. Infect Immun. 1978;19:416-420.
21. Meenken C, Rothova A, de Waal LP, van der Horst AR, Mesman BJ, Kijlstra A. HLA typing in congenital toxoplasmosis. Br J Ophthalmol. 1995;79:494-497.
22. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240:516-518.
23. Nagineni CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun. 1996;64:4188-4196.
24. Suzuki Y, Joh K, Kobayashi A. Tumor necrosis factor-independent protective effect of recombinant IFN-γ against acute toxoplasmosis in T cell-deficient mice. J Immunol. 1991;147:2728-2733.
25. Wille U, Villegas EN, Craig L, Peach R, Hunter CA. Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice. Infect Immun. 2002;70:6940-6947.
26. Shirahata T, Mori A, Ishikawa H, Goto H. Strain differences of interferon-generating capacity and resistance in Toxoplasma-infected mice. Microbiol Immunol. 1986;30:1307-1316.
27. + T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med. 1996;184:597-607.
28. Bohne W, Heesemann J, Gross U. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun. 1994;62:1761-1767.
29. Gross U, Bohne W, Soête M, Dubremets JF. Developmental differentiation between tachyzoites and bradyzoites of Toxoplasma gondii. Parasitol Today. 1996;12:30-33.
30. Yano A, Mun H-S, Chen M, et al. Roles of IFN-γ on stage conversion of an obligate intracellular protozoan parasite, Toxoplasma gondii. Intern Rev Immunol. 2002;21:405-421.
31. Roberts F, McLeod R. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today. 1999;15:51-57.
32. Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 1969;81:481-493.
33. Holland GN, Engstrom RE Jr, Glasgow BJ, et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988;106:653-667.
34. Yeo JH, Jakobiec FA, Iwamoto T, Richard G, Kreissig I. Opportunistic toxoplasmic retinochoroiditis following chemotherapy for systemic lymphoma: a light and electron microscopic study. Ophthalmology. 1983;90:885-898.
35. Moorthy RS, Smith RE, Rao NA. Progressive ocular toxoplasmosis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:742-747.
36. Holland GN, O'Connor R, Belfort R Jr, Remington JS. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis, MO: Mosby;1996:1183-1223.
37. Zimmerman LE: Ocular pathology of toxoplasmosis. Surv Ophthalmol. 1961;6:832-839;discussion 839-856.
38. Rehder JR, Burnier M Jr, Pavesio CE, et al. Acute unilateral toxoplasmic iridocyclitis in an AIDS patient. Am J Ophthalmol. 1988;106:740-741.
39. Bottoni F, Gonnella P, Autelitano A, Orzalesi N. Diffuse necrotizing retinochoroiditis in a child with AIDS and toxoplasmic encephalitis. Graefe's Arch Clin Exp Ophthalmol. 1990;228:36-39.
40. Tirard V, Niel G, Rosenheim M, et al. Diagnosis of toxoplasmosis in patients with AIDS by isolation of the parasite from the blood. N Engl J Med. 1991;324:634.
41. Luo W, Aosai F, Ueda M, et al. Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR. J Parasitol. 1997;83:1070-1074.
42. Manschot WA, Daamen CBF. Connatal ocular toxoplasmosis. Arch Ophthalmol. 1965;74:48-54.
43. Berengo A, Frezzotti R. Active neuro-ophthalmic toxoplasmosis: a clinical study on nineteen patients. Adv Ophthalmol. 1962;12:265-343.
44. Roberts F, Mets MB, Ferguson DJ, et al. Histopathological features of ocular toxoplasmosis in the fetus and infant. Arch Ophthalmol. 2001;119:51-58.
45. Falcone PM, Notis C, Merhige K. Toxoplasmic papillitis as the initial manifestation of acquired immunodeficiency syndrome. Ann Ophthalmol. 1993;25:56-57.
46. Schuman JS, Weinberg RS, Ferry AP, Guerry RK. Toxoplasmic scleritis. Ophthalmology. 1988;95:1399-1403.
47. Holland GN, Muccioli C, Silveira C, Weisz JM, Belfort R Jr, O'Connor GR. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol. 1999;128:413-420.
48. Geier SA, Klauss V, Goebel FD. Ocular microangiopathic syndrome in patients with acquired immunodeficiency syndrome and its relationship to alterations in cell adhesion and in blood flow. Ger J Ophthalmol. 1994;3:414-421.
49. Webb RM, Tabbara KF, O'Connor GR. Retinal vasculitis in ocular toxoplasmosis in nonhuman primates. Retina. 1984;4:182-188.